Orbis India Country Director recognized by the Lions Council of India for efforts to expand access to quality eye care among underserved communities.
Knowledge paper highlights biosimilars, biologics, AI-driven drug discovery and regulatory excellence as key growth drivers for the next phase of India's pharma expansion
KIHT can now conduct clinical research for drugs and medical devices, strengthening evidence generation and healthcare innovation
Company experts to participate in eight sessions covering AI-powered clinical development, regulatory innovation, oncology research, and patient engagement
The Prayagraj lab is designed to handle both routine and specialised testing
Collaboration aims to accelerate medicinal chemistry decision-making, reduce synthesis burden and strengthen data-secure AI adoption in drug discovery
Approval expands treatment options for patients with unresectable or metastatic HER2-positive breast cancer
7.5 crore antenatal check-ups and 1.2 crore high-risk pregnancies identified under flagship programme as maternal and neonatal mortality declines
The landmark legislation has laid the foundation for a skilled, regulated and globally competitive Allied and Healthcare Professional workforce, reshaping healthcare education and delivery across India
Consolidated entity plans to strengthen specialty pharmaceutical offerings, expand manufacturing capacity, and accelerate global market penetration across emerging regions
Subscribe To Our Newsletter & Stay Updated
